Friday, December 23, 2016 11:03:43 AM
Regarding the "news" that they are selling the entity that they are selling, I never even knew about it, clearly they were never doing much with it and I doubt it's sale is of little consequence. This pps increase I believe is unrelated. Frankly I think the pps was simply under where it should have been and if this continues on a mild increase, that'll just be a correction.
The main focus will always be emesyl. And so far, despite many true and good efforts, emesyl has yet to grow wings.
I did recently recommend emesyl to a friend, since I actually had very good results from it. It's fascinating that you can have a product which genuinely works, plus be actively trying to sell it, and yet still not go anywhere.
I'm not selling my stock till I get my buy in price from two years ago- 3 cents.
Someday I believe it WILL get there.
Happy 2017 everyone.
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM